Signaling pathways
- BA5647 BevenopranSummary: A peripheral mu opioid receptor antagonist.
- BA5648 LY255582Summary: LY255582 is a pan-opioid antagonist.
- BA5649 NaltrexoneSummary: Naltrexone is an antagonist.
- BA5650 LY2444296Summary: LY2444296 is an orally bioactive, high affinity, selective, short-acting antagonist.
- BA5651 J-113397Summary: The first potent and selective nonpeptidyl antagonist.
- BA5652 BMS-986121Summary: BMS-986121 is a positive alteration modifier (PAM).
- BA5653 DalarginSummary: Dalargin is a potent delta-opioid receptor agonist.
- BA5654 SamidorphanSummary: Samidorphan (ALKS-33) is an orally active systemic modulator with high affinity for binding to μ-opioid, κ-opioid and δ-opioid receptors.
- BA5655 NalmefeneSummary: Nalmefene is a long-acting opioid agent (and antagonist) and a partial agonist.
- BA5656 NaloxoneSummary: Naloxone is an antagonist.